Expression of Epstein-Barr virus membrane antigen gp340/220 in mouse fibroblasts using a bovine papillomavirus vector.
Affiliation
Paterson Institute for Cancer Research, Withington, Manchester, U.K.Issue Date
1989-03
Metadata
Show full item recordAbstract
Epstein-Barr virus (EBV) membrane antigen glycoproteins gp340 and gp220 are encoded by a single gene. We have inserted this gene into a bovine papillomavirus (BPV) vector and expressed gp340/220 in mammalian cells under the control of the mouse metallothionein promoter. The proteins produced were of similar Mr, showed similar antigenic specificity and were transported to the same subcellular location as the authentic gp340/220. The inclusion of heavy metal ions in the medium had no effect on the levels of gp340/220, which were approximately the same as those found in standard EBV-transformed lymphoblastoid cell lines, e.g. B95-8. Cells that expressed gp340/220 were selected by several rounds of fluorescence-activated cell sorting, but on passage they rapidly lost the ability to express this glycoprotein. In contrast to this we found that BPV-transformed cells expressing a truncated version of gp340/220 still produced it at significant levels after extended passage.Citation
Expression of Epstein-Barr virus membrane antigen gp340/220 in mouse fibroblasts using a bovine papillomavirus vector. 1989, 70 ( Pt 3):729-34 J. Gen. Virol.Journal
The Journal of General VirologyDOI
10.1099/0022-1317-70-3-729PubMed ID
2543757Type
ArticleLanguage
enISSN
0022-1317ae974a485f413a2113503eed53cd6c53
10.1099/0022-1317-70-3-729
Scopus Count
Collections
Related articles
- Protective immunization against Epstein-Barr virus-induced disease in cottontop tamarins using the virus envelope glycoprotein gp340 produced from a bovine papillomavirus expression vector.
- Authors: Finerty S, Tarlton J, Mackett M, Conway M, Arrand JR, Watkins PE, Morgan AJ
- Issue date: 1992 Feb
- Purification and characterization of Epstein-Barr virus gp340/220 produced by a bovine papillomavirus virus expression vector system.
- Authors: Madej M, Conway MJ, Morgan AJ, Sweet J, Wallace L, Qualtiere LF, Arrand JR, Mackett M
- Issue date: 1992
- MHC class II-restricted presentation of endogenously synthesized antigen: Epstein-Barr virus transformed B cell lines can present the viral glycoprotein gp340 by two distinct pathways.
- Authors: Lee SP, Wallace LE, Mackett M, Arrand JR, Searle PF, Rowe M, Rickinson AB
- Issue date: 1993 May
- In vitro T cell responses to a candidate Epstein-Barr virus vaccine: human CD4+ T cell clones specific for the major envelope glycoprotein gp340.
- Authors: Ulaeto D, Wallace L, Morgan A, Morein B, Rickinson AB
- Issue date: 1988 Nov
- Recombinant vaccinia virus induces neutralising antibodies in rabbits against Epstein-Barr virus membrane antigen gp340.
- Authors: Mackett M, Arrand JR
- Issue date: 1985 Dec 1